Skip to main content
TipRanks
Go Ultimate75% OFF
CHARM Therapeutics logo

CHARM Therapeutics: Valuation, Funding & Investors

London, GBhttps://www.charmtx.com/Precision Medicine

CHARM Therapeutics is a biotechnology company focused on developing next-generation precision oncology treatments, specifically targeting acute myeloid leukemia (AML). Utilizing its proprietary AI-driven drug discovery platform, DragonFold, CHARM is advancing a novel menin inhibitor designed to overcome resistance mutations that limit the efficacy of first-generation therapies. The company's innovative approach aims to provide more durable and effective treatment options for AML patients, with clinical development of its lead candidate expected to commence in early 2026. Based in Cambridge and London, CHARM is supported by a strong syndicate of international investors.

Leadership & Board

Current Number of Employees
29
Current LinkedIn Followers
13,489

Latest Estimated Valuation

Total Amount Raised
$80M
Total Funding Rounds
1
Latest Funding Amount
$80M
Latest Funding Round
Series B

Company Momentum

Positive
Articles Published on TipRanks2
LinkedIn Trend+0.17% followers
Workforce Trend+0.0% employees

CHARM Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

CHARM Therapeutics had 29 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

29Latest Employee Count
0(0.00%)Week-Over-Week Change
010203040Mar 02, 2026Mar 16, 2026Mar 30, 2026Apr 13, 2026May 04, 2026May 18, 2026Jun 01, 2026Jun 15, 2026Jun 29, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

CHARM Therapeutics had 13,489 followers as of November 16, 2026. The number of followers increased by 23 (0.17%) week-over-week.

13,489Latest Followers Count
23(0.17%)Week-Over-Week Change
05,00010,00015,00020,000Mar 02, 2026Mar 16, 2026Mar 30, 2026Apr 13, 2026May 04, 2026May 18, 2026Jun 01, 2026Jun 15, 2026Jun 29, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 02, 2025Series B$80.00M―

Investors

Investor NameFunding Round
Khosla VenturesSeries B
OrbiMedSeries B
SR OneSeries B
F-PrimeSeries B
NVIDIASeries B
New Enterprise AssociatesSeries B

Similar Companies

A snapshot of private companies similar to CHARM Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis